New & Notable
Enhancing patient care with clinical decision-making AI
Clair by CaryHealth uses AI to enhance clinical decision-making, providing healthcare professionals with fast, evidence-based insights and seamless integration.
How will the NOPAIN Act impact Medicare beneficiaries?
The NOPAIN Act might alter Medicare prescribing by mandating coverage and expanding access to non-opioid treatments, promoting research, and facilitating education.
March of Dimes report: 2.3M women live in maternal care deserts
According to a 2024 report by March of Dimes, 35% of U.S. counties are maternity care deserts, with roughly 2.3 million women of reproductive age living in these areas.
U.S. House passes BIOSECURE Act, targeting Chinese biotech
The U.S. House passed the BIOSECURE Act, which targets Chinese biotech firms to safeguard national security and impact the drug supply chain.
Insights
Insights is the research division of Xtelligent Healthcare Media. Our work aims to leverage Xtelligent’s diverse readership of healthcare professionals across various sectors of the industry to understand real-world challenges and identify effective solutions.
Access All Reports
Healthcare Strategies: A Podcast
-
A podcast for healthcare professionals seeking solutions to today's and tomorrow's top challenges. Hosted by the editors of Xtelligent Healthcare Media, this podcast series focuses on real-world use cases that are leading to tangible improvements in care quality, outcomes, and cost.
Guests from leading provider, payer, government, and other organizations share their approaches to transforming healthcare in a meaningful and lasting way.
View All Episodes
Latest News
-
AMA reports low PBM competition, high vertical integration
A 2024 AMA annual report confirms low competition and high vertical integration in PBM markets, urging regulatory action to protect patients and ensure affordability.
-
Study uncovers risks of buying semaglutide online
The rise of unregulated online sales of semaglutide poses serious health risks, emphasizing the need for professional guidance and stricter regulation.
-
Reviewing the CDC 2024-2025 respiratory virus season outlook
The CDC outlines the 2024-2025 respiratory virus season outlook, indicating that combined peak hospitalization rates will be similar to or lower than the previous year.
-
FDA clears automatic insulin pump for type 2 diabetes
Automated insulin pumps have previously been available only for type 1 diabetes. However, the FDA recently cleared the Insulet SmartAdjust, the first automatic insulin pump for type 2 diabetes.
-
Eli Lilly's single-dose Zepbound vials expand obesity care
Eli Lilly introduced single-dose vials of Zepbound (tirzepatide) to offer flexible dosing, cost savings and improved obesity care through its Lilly Direct service.
-
FDA approves updated mRNA COVID-19 vaccines
The updated Moderna, Pfizer-BioNTech, Spikevax, and Comirnaty mRNA COVID-19 vaccines, also called the 2024-2025 formulations, should protect against recently circulating strains.
Features
-
Understanding significant mosquito-borne diseases
Common mosquito-borne illnesses, such as Zika virus, West Nile virus, Chikungunya virus, dengue, and malaria, pose public health threats for various communities.
-
Formulating a specialty drug management playbook using expert insights
Using this playbook, healthcare organizations can better navigate the complexities of specialty drug management to optimize care, control costs, and improve patient outcomes.
-
Exploring trends shaping the future of specialty pharmacy
The pharmacy industry is evolving with specialty drugs, requiring advanced management and technology solutions to control costs and improve patient outcomes.
-
Recognizing the growing impact of climate change on infectious diseases
As climate change worsens, its growing impact on global health is becoming alarmingly evident, particularly through the spread of infectious diseases.